Subscribe
Sign in
Home
Podcast
Notes
Archive
About
Latest
Top
Grail Hit with Shareholder Class Action Suit Over NHS-Galleri Trial Remarks
The suit alleges that Grail executives concealed the “true state” of the company’s NHS-Galleri trial, which did not meet its primary endpoint.
Jun 12
•
Andrew P. Han
University of Exeter to Profile Epigenetics of UK Biobank Samples with Illumina Tech
University of Exeter will profile DNA methylation across one million genomic sites with funding from the Novo Nordisk Foundation and technical support…
Jun 12
•
Andrew P. Han
1
All Things Q1 with Wall Street Analyst Kyle Mikson
Illumina, Natera, 10x Genomics, ASCO headlines, Seer, PacBio, summer vacation plans, and more.
Jun 12
•
Andrew P. Han
44:39
FDA Approves Guardant Test as Companion Diagnostic for First-Line Lung Cancer Drug
The liquid biopsy test will identify patients with HER2 (ERBB2) mutations eligible for Boehringer Ingelheim's newly approved first-line non-small cell…
Jun 11
•
Andrew P. Han
Element Biosciences Nabs $175M Investment from Samsung
The financing is part of Element’s “upsized” Series E round and reportedly makes Samsung the company’s largest shareholder.
Jun 10
•
Andrew P. Han
Ion Genomics Newsletter: June 9, 2026
Illumina’s StrataMap Spatial, 10x acquires protein tech, AI companies ask Congress for biosecurity regulation, Google DeepMind Launches genomic data…
Jun 9
•
Andrew P. Han
1
10x Genomics Acquires Tech for Protein Detection Throughout Single Cells
The Proteintech Genomics assays were built to be compatible with 10x’s Flex single-cell sequencing technology and could help build datasets for training…
Jun 9
•
Andrew P. Han
Google DeepMind, Wellcome Sanger Launch AI-Focused Genomic Data Consortium
Google’s DeepMind and its philanthropic arm have committed $25 million to build large-scale, biological datasets catered to AI models.
Jun 8
•
Andrew P. Han
Genomic Medicine Sweden, Hartwig Medical Foundation Partner on WGS in Cancer Care
The organizations will work to implement WGS as a routine diagnostic tool and build cross-border data infrastructure for precision oncology research.
Jun 5
•
Andrew P. Han
Sophia Genetics, Memorial Sloan Kettering Ink MOU for Precision Oncology Hub
The two institutions will launch a joint venture combining MSKCC's clinical genomic datasets with Sophia’s AI platform.
Jun 5
•
Andrew P. Han
Spatial Perturb-seq, so hot right now! With Alexander Nevue
This juncture of CRISPR-based screening and spatial transcriptomics is one of the hottest areas in molecular biology right now.
Jun 5
•
Andrew P. Han
42:11
Natera, CytoDyn to Use ctDNA Testing in Metastatic Colorectal Cancer Drug Study
Natera's Signatera assay will analyze tumor DNA dynamics in CytoDyn's Phase II trial of leronlimab.
Jun 4
•
Andrew P. Han
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
